![Marc-André D'Aoust](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc-André D'Aoust
Technik-/Wissenschafts-/F&E-Leiter bei Medicago, Inc.
Aktive Positionen von Marc-André D'Aoust
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | - |
Karriereverlauf von Marc-André D'Aoust
Statistik
International
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Börse
- Insiders
- Marc-André D'Aoust
- Erfahrung